IFG Advisory’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
IFG Advisory's GILD Position: Q2 2021 in Review
IFG Advisory sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 4,864 shares — an estimated $314K sold.
IFG Advisory first reported a position in GILD in Q4 2017 and held it in 14 quarters. The position peaked at $1.07M in Q4 2017. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.
- IFG Advisory reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
- IFG Advisory sold 4,864 Gilead Sciences shares in Q2 2021, an estimated $314K.
- IFG Advisory first reported a position in Gilead Sciences in Q4 2017 and held it in 14 quarters.
- IFG Advisory's Gilead Sciences position peaked at $1.07M in Q4 2017.
- 1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.
Based on IFG Advisory's 13F filing for Q2 2021, filed 21 Jul 2021.